CT引导下导管抽吸与溶栓治疗高血压性基底节血肿:技术与短期预后比较
本研究纳入10例自发性高血压性基底节出血患者,行CT引导下血肿腔导管置入、抽吸并每12小时注入25,000 IU尿激酶溶栓,并与12例年龄性别匹配的保守治疗患者比较。导管组6个月功能预后优于保守组,但差异无统计学意义;导管组平均血肿体积减少83.14%,保守组有血肿扩大、脑积水及死亡发生。结论认为该技术在现有资源下可行。
要点
- CT引导下导管抽吸联合尿激酶溶栓可用于高血压性基底节血肿清除。
- 导管组6个月功能预后优于保守组但差异未达统计学显著。
- 导管组平均血肿体积减少83.14%,部分出现轻度气颅并自行缓解。
核心结论
- 使用基础神经外科器械和现有资源(如CT)清除高血压性基底节血肿是可行的,与单纯保守治疗相比功能预后有所改善。
研究设计与样本
- 研究纳入10例自发性基底节出血患者行CT引导下导管置入、血肿抽吸及尿激酶溶栓,并与12例年龄和性别匹配的保守治疗患者进行对比分析。
主要发现
- 导管组6个月平均Glasgow结局量表评分改善0.4,保守组改善0.08。
- 导管组改良Rankin量表评分改善-0.8,保守组改善-0.25。
- 导管组美国国立卫生研究院卒中量表评分改善-6.8分,保守组改善-1.5分,但上述差异均无统计学显著性。
- 导管组平均血肿体积减少83.14%。
- 保守组12例中2例(16.6%)血肿扩大、6例(50%)发生脑积水、2例(16.6%)死亡;导管组10例中4例(40%)出现轻度气颅并缓解。
临床怎么用
- 对于高血压性基底节血肿,可考虑在CT引导下置管抽吸并每12小时注入25,000 IU尿激酶进行溶栓,但需注意气颅等并发症。
局限性
- 样本量小(导管组10例,保守组12例),功能预后差异未达统计学显著,结论需更大样本研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Minimally invasive techniques of hematoma evacuation with or without the use of thrombolytic agents to lyse the clots have shown promising outcomes compared to open surgical evacuation. However, there is a dearth of literature in developing nations. The objective in this study was to evacuate spontaneous hypertensive basal ganglionic hemorrhages using computed tomography (CT)-guided catheter insertion, hematoma aspiration, and lysis with thrombolytic agents and analyze the efficacy and outcomes. METHODS: Ten patients with spontaneous basal ganglionic hemorrhage underwent CT-guided clot catheter insertion, followed by aspiration of hematoma and clot lysis using 25,000 IU urokinase instilled every 12 hours. Details including symptoms, clinical and radiologic findings, efficacy of the technique, functional outcomes during follow-up, length of stay, and cost were recorded. Relevant details for 12 age- and sex-matched conservatively treated patients were compared. RESULTS: Functional outcome in the catheter group at 6 months was better than the medically managed group, with improved mean Glasgow Outcome Scale score (0.4 vs. 0.08), reduced modified Rankin scale score (-0.8 vs. -0.25), and reduced National Institutes of Health Stroke Scale score (-6.8 vs. -1.5 points). However, it was not statistically significant. Average hematoma volume reduction in the catheter group was 83.14%. In the medically managed group, 2 of 12 patients (16.6%) had hematoma expansion, 6 patients (50%) developed hydrocephalus, and 2 patients (16.6%) died. In the catheter group, 4 of 10 patients (40%) developed mild pneumocephalus that resolved. CONCLUSIONS: The evacuation of hypertensive basal ganglionic hematomas is feasible with basic neurosurgical instruments and existing resources (e.g., CT scan) with improved functional outcome compared with conservative treatment alone.
引用
- Hegde N, Khanapure KS, Furtado SV, et al. Computed Tomography-Guided Catheter Aspiration and Thrombolysis of Hypertensive Basal Ganglionic Hematomas: Technique and Short-Term Outcome Comparison. World Neurosurg. 2021. PMID: 34688940. doi:10.1016/j.wneu.2021.10.123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。